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A physiological increase in maternal cortisol alters
uteroplacental metabolism in the pregnant ewe
O. R. Vaughan, K. L. Davies, J. W. Ward, M. J. de Blasio and A. L. Fowden
Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, CB2 3EG, UK
Key points
 Fetal nutrient supply is dependent, in part, upon the transport capacity and metabolism of the
placenta.
 The stress hormone, cortisol, alters metabolism in the adult and fetus but it is not known
whether cortisol in the pregnant mother affects metabolism of the placenta.
 In this study, when cortisol concentrations were raised in pregnant sheep by infusion,
proportionatelymore of the glucose taken up by the uterus was consumed by the uteroplacental
tissues while less was transferred to the fetus, despite an increased placental glucose transport
capacity. Concomitantly, the uteroplacental tissues produced lactate at a greater rate.
 The results show that maternal cortisol concentrations regulate uteroplacental glycolytic
metabolism, producing lactate for use in utero.
 Prolonged increases in placental lactate production induced by cortisol overexposure may
contribute to the adverse effects of maternal stress on fetal wellbeing.
Abstract Fetal nutrition is determined by maternal availability, placental transport and
uteroplacental metabolism of carbohydrates. Cortisol affects maternal and fetal metabolism, but
whether maternal cortisol concentrations within the physiological range regulate uteroplacental
carbohydratemetabolism remains unknown.This studydetermined the effect ofmaternal cortisol
infusion (1.2 mg kg−1 day−1 I.V. for 5 days, n = 20) on fetal glucose, lactate and oxygen supplies
in pregnant ewes on day 130 of pregnancy (term = 145 days). Compared to saline infusion
(n = 21), cortisol infusion increased maternal, but not fetal, plasma cortisol (P < 0.05). Cortisol
infusion also raised maternal insulin, glucose and lactate concentrations, and blood pH, PCO2
and HCO3− concentration. Although total uterine glucose uptake determined by Fick’s principle
was unaffected, a greater proportion was consumed by the uteroplacental tissues, so net fetal
glucose uptake was 29% lower in cortisol-infused than control ewes (P < 0.05). Concomitantly,
uteroplacental lactate production was > 2-fold greater in cortisol- than saline-treated ewes
(P < 0.05), although uteroplacental O2 consumption was unaffected by maternal treatment.
Materno-fetal clearance of non-metabolizable [3H]methyl-D-glucose and placental SLC2A8
(glucose transporter 8) gene expression were also greater with cortisol treatment. Fetal plasma
glucose, lactate or α-amino nitrogen concentrations were unaffected by treatment although
fetal plasma fructose and hepatic lactate dehydrogenase activity were greater in cortisol- than
saline-treated ewes (P < 0.05). Fetal plasma insulin levels and body weight were also unaffected
by maternal treatment. During stress, cortisol-dependent regulation of uteroplacental glycolysis
may allow increased maternal control over fetal nutrition and metabolism. However, when
maternal cortisol concentrations are raised chronically, prolonged elevation of uteroplacental
lactate production may compromise fetal wellbeing.
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Introduction
The fetus requires nutrients such as glucose and lactate for
both oxidative metabolism and tissue accretion in utero
(Barcroft et al. 1939; Battaglia & Meschia, 1988; Fowden,
1997). These nutrients must ultimately be acquired from
the mother, via the placenta. Uterine uptake and trans-
placental transport of glucose occur by facilitateddiffusion
(Sibley et al. 1997). This depends on the materno-fetal
glucose concentration gradient, the surface area of the
placenta for transport and the abundance of facilitative
glucose transporters (GLUTs) 1, 3 and 8 in the ovine
placenta (Limesand et al. 2004; Wooding et al. 2005). The
net amount of glucose reaching the fetus also depends
on the rate of glucose consumption by the uteroplacental
tissues for their ownmetabolic activities (Hay et al. 1990).
In sheep and other species, about half of the glucose taken
up by the gravid uterus is used by the uteroplacental
tissues for both oxidative and non-oxidative metabolism,
including glycolysis (Aldoretta & Hay, 1999; Fowden
et al. 2001). The lactate produced glycolytically is then
released into both maternal and fetal circulations (Sparks
et al. 1982). The energy produced by the uteroplacental
tissues is used, in part, for the active transport and
transamination of amino acids needed to meet the fetal
nutrient requirements (Battaglia & Regnault, 2001). Thus,
uteroplacentalmetabolism is an important determinant of
the fetal nutrient supply.
Glucocorticoids, like cortisol, regulate metabolism in
adult and fetal tissues (McMahon et al. 1988; Fowden
et al. 1998). Glucocorticoid concentrations rise normally
in late pregnancy (Bell et al. 1991; Fowden et al. 1998;
Jensen et al. 2002a) but may be elevated before term if
the mother is exposed to stresses such as malnutrition,
infection or transport (Fowden & Silver, 1985; Edwards &
McMillen, 2001; Kabaroff et al. 2006; Miranda-de la Lama
et al. 2012). When maternal cortisol concentrations are
increased exogenously in pregnant sheep for  10 days
during late gestation, there are alterations in maternal
glucose concentrations and uterine blood flow, which are
associated with impaired fetoplacental growth and poor
fetal viability (Jensen et al. 2005, 2010; Keller-Wood et al.
2014). In part, these changes may relate to alterations
in uteroplacental metabolism and, hence, fetal nutrition.
Certainly, infusing cortisol directly into fetal sheep alters
glucose partitioning between uteroplacental and fetal
tissues (Ward et al. 2004). Moreover, raising cortico-
sterone concentration in pregnant mice to values seen in
stressful conditions reduces the glucose transport capacity
of the placenta (Vaughan et al. 2012, 2015). However,
whether maternal cortisol concentrations influence net
fetal carbohydrate uptake by regulating uteroplacental
carbohydratemetabolismanddelivery to the fetus remains
unknown.
This study tested the hypothesis that raising maternal
cortisol concentrations by exogenous infusion would alter
uteroplacental metabolism and glucose transport capacity
in pregnant sheep. Specifically, the experiments quantified
theuterine uptake, uteroplacental consumption, umbilical
uptake and fetal concentrations of glucose and
lactate, along with the transplacental clearance of a
non-metabolizable glucose tracer, [3H]methyl-D-glucose
([3H]MeDG). Since glucocorticoids may also influence
fetal availability of glucose by altering its rate of end-
ogenous production or insulin-stimulated utilization,
the physiological measurements of nutrient uptake were
related to biochemical indices of hepatic glucogenic
capacity and tissue insulin signalling in the fetus.
Methods
Animals
All procedures were conducted under the Animals
(Scientific Procedures) Act 1986. Forty-three Welsh
mountain ewes carrying single fetuses of known
gestational age were used in this study. Ewes were
housed individually during the experimental period
and maintained on concentrate (200 g day−1, Beart,
Stowbridge, Suffolk, UK) and hay and water ad libitum.
Food, but not water, was withdrawn for 18–24 h prior to
surgery.
Surgical procedures
Ewes and their fetuses were catheterized under general
anaesthesia (2 mg kg−1 alfaxalone, I.V. and 2% iso-
fluorane in 5:1O2:NO2 inhaled) at day118 of pregnancy
(term= 145 days). Catheterswere inserted into the uterine
vein, and the dorsal aorta and caudal vena cava of both the
mother and fetus in all animals and also into the umbilical
vein of 24 fetuses, as described previously (Fowden &
Silver, 1995). Analgesia (1 mg kg−1 carprofen, S.C.) and
prophylactic antibiotics (20–30 mg kg−1 benzylpenicillin,
I.M. mother and I.V. fetus) were administered at the time
of surgery. After recovery from anaesthesia, the ewe was
returned to her home pen and the catheters were flushed
daily until beginning the experimental procedures.
Experimental procedures
After at least 5 days post-operative recovery, ewes
were infused either with cortisol (1.2 mg kg−1 day−1
Solucortef, Pharmacia, i.v., n = 20) or saline (0.9% w/v,
n = 21) for a further 5 days, beginning on day 125
of pregnancy. Cortisol or saline solutions, which were
replaced daily, were infused using an ambulatory infusion
pump (MS16A, Graseby, Ashford, UK) contained in a
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pouch secured to the flank of the ewe. On the final
day of infusion (130.1 ± 0.3 days), before the morning
feed of concentrates, a metabolic study was conducted
to determine steady-state uterine and umbilical blood
flows and substrate uptakes in the subset of animals
in which all catheters remained patent (n = 24). Anti-
pyrine (80–100 mg ml−1 in saline 0.9% w/v) was infused
at a known rate (mean 8.3 ± 0.2 mg min−1) into the
fetal caudal vena cava following an initial priming bolus
of 5 ml. Simultaneous blood samples were collected
from the umbilical vein, fetal aorta, uterine vein and
maternal aorta immediately before the start of infusion
and 120, 140, 160 and 180 min later, when steady state
had been reached. Uterine and umbilical blood flows
were quantified using the antipyrine steady-state diffusion
technique (Fowden & Hay, 1988; Fowden & Silver, 1995).
Net uterine and umbilical uptakes of glucose, lactate and
oxygen were then calculated by Fick’s principle as the
product of blood flow and the arterio-venous difference
in concentration of each substance, determined as
below. In 16 animals, [3H]methyl-D-glucose ([3H]MeDG,
40 μCi ml−1) was added to the antipyrine infusate in
order to measure transplacental glucose clearance on the
final day of saline or cortisol infusion (Owens et al.
1987).
The simultaneous blood samples were analysed
immediately for pH, HCO3− concentration and partial
pressures of O2 and CO2, corrected for maternal (37°C)
or fetal (39°C) temperature, using an ABL5 Radio-
meter (Radiometer Copenhagen, Crawley, UK). Blood
oxygen content was calculated from the percentage
of O2 saturation and haemoglobin concentration
measured using an ABL80 haemoximeter (also Radio-
meter Copenhagen). An aliquot (0.5 ml) of each blood
sample was then deproteinized with zinc sulphate and
barium hydroxide (both 0.15 M) and the remainder trans-
ferred to a chilled, EDTA-coated tube. All samples were
then centrifuged (1500 g, 4°C, 5min) and the supernatants
stored at −20°C until required for analysis.
At the end of the experiment, all ewes and fetuses were
killed with a lethal dose of anaesthetic (200 mg kg−1
sodium pentobarbitone, Pentoject, Animalcare Ltd,
Dunnington, York, UK). After checking the correct
positioning of all catheters, the fetus and uteroplacental
tissues were weighed and placentomes counted and
classified into the less everted (A/B) ormore everted (C/D)
subtype as described previously (Vatnick et al. 1991).
Samples of placentomes, fetal andmaternal liver, and fetal
muscle were rapidly frozen in liquid nitrogen then stored
at −80°C.
Biochemical analyses
Whole blood concentrations of antipyrine, glucose and
lactate were determined in all five sets of simultaneous
samples obtained during the study. Antipyrine
concentration was measured in deproteinized blood by
the addition of nitrous acid to make 4-nitroso-antipyrine,
which was determined by spectrophotometry at 340 nm
(Edwards, 1959). Glucose wasmeasured colourimetrically
in deproteinized blood using glucose oxidase (Fowden
& Silver, 1995). Blood lactate content was determined
using a YSI 2300 Stat Plus instrument (Yellow Springs,
Farnborough, UK). [3H]MeDG content was determined
in all fetal (0.2 ml) and maternal (0.4 ml) plasma samples
by liquid scintillation counting (LKB Wallac Rackbeta).
Arterial plasma samples were also analysed for glucose,
lactate (YSI 2300 Stat Plus), fructose (Abcam, Cambridge,
UK) and α-amino nitrogen concentrations using pre-
viously published methods (Evans et al. 1993).
Cortisol and insulin concentrations were determined
in maternal and fetal EDTA plasma collected under basal
conditions, with the ewe unrestrained in her home pen,
on the morning of the study before antipyrine infusion
was begun. Cortisol concentration was measured in
ethanol-extracted plasma using a commercially available
ELISA (IBL International, Hamburg, Germany) used pre-
viously for ovine plasma (Kabaroff et al. 2006). Mean
recovery of cortisol standard added to stripped sheep
plasma was 105 ± 1% while 2-fold and 4-fold dilutions
of a fetal plasma sample gave corrected values of 94%
and 101% of the original concentration, respectively. For
two control samples with mean cortisol concentrations
of 77 ± 3 and 221 ± 5 ng ml−1, the mean inter-assay
and intra-assay coefficients of variability were 4%
and 13%, respectively. The limit of detection of the
assay was 2.4 ng ml−1. An ovine-specific ELISA was
used for measurement of plasma insulin concentrations
(Mercodia, Uppsala, Sweden). The limit of detection was
0.025 ng ml−1 and the intra-assay coefficient of variation
was 2%.
Lactate dehydrogenase activity was measured in frozen
liver and placentome samples homogenized in 0.25 M
sucrose buffer. The homogenate was incubated at 37°C
for 10 min in the presence of NADH (0.3 mM). Pyruvate
(1.2 mmM) was added to the reaction tube and the rate of
oxidation of NADH followed by the change in absorbance
at 340 nm for 30 s. Activities of the hepatic gluconeogenic
enzymes fructose-1,6-bisphosphatase (FBPase) and
glucose-6-phosphatase (G6Pase), along with hepatic
glycogen content were measured as described pre-
viously (Fowden et al. 1993). Tissue protein content
was determined using the Lowry assay (Forhead et al.
2003).
Gene expression
RNA was extracted from maternal and fetal liver and
from one placentome of the most abundant sub-
type from each animal (RNeasy Mini, Qiagen) and
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reverse transcribed to cDNA (High Capacity Reverse
Transcription Kit, Life Technologies). The expression
of the glucocorticoid receptor (NR3C1, forward (F)-
CAAGCTGGAATGAACCTGGAA, reverse (R)-AAGT
TTCTTGCGAGACTCCTG) and 11β-hydroxysteroid
dehydrogenase enzymes (HSD1, F-GATGGGAGCTC
ACGTGGTAG, R-CTCCAGGCAGCGGGATAC; and
HSD2, F-CCGGCTGGATCGTGTTGTC, R-GTTGCCA
AAACCAGAGTCACA) was quantified in all three
tissues. Additionally, placentome tissue was assessed
for expression of the facilitative glucose transporters
(SLC2A1, F-CATGTATGTGGGGGAGGTGT, R-TGGTT
GCCCATGATGGAGT; SLC2A3, F-CAGCTCTCTGG
GATCAACGC, R-TGACCACACCTGCACCGATA; and
SLC2A8, F-GATGGTGGTCACAGGCATCC, R- GGTC
TCGGGCATGAAACACA; Limesand et al. 2004). Liver
expression was quantified for the gluconeogenic
enzymes (G6PC, F-TGTCTGCCTGTCACGAATCT, R-
TCTGGATGTGGCGGAAAGTC; and PCK1, F-GGA
GGAGGGTGTGATCAAGAG, R- CAATTCTGGCCAC
ATCCCTGG; Thorn et al. 2009). Real-time PCR was
carried out using MESA green reagents (Eurogentec)
and the Light Cycler 480 instrument (Roche). Expression
level in unknown samples was determined relative
to a standard curve of pooled, 2-fold serial diluted
cDNA and normalized to the geometric mean of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH,
F-TGGTGAAGGTCGGAGTGAAC, R-ACGATGTCCAC
TTTGCCAGT) and hypoxanthine phosphoribosyl
transferase (HPRT1, F-TATGCTGAGGATTTGGAGA
AGGT, R-ATCACATCTCGAGCCAGTCG) abundance.
Amplicon size for each primer pair was verified by
running the PCR product on an agarose gel.
Protein abundance
Total protein was extracted from placenta, fetal liver and
skeletalmuscle (n= 7per group). Protein extracts resolved
by electrophoresis were transferred to nitrocellulose
membrane and probed with antibodies specific to the
insulin receptor (Santa Cruz Biotechnology, Dallas,
TX, USA), Akt and phosphorylated Akt (Ser473) (Cell
Signaling, Danvers, MA, USA). Protein abundance was
quantified from the intensity of specific bands visualized
by enhanced chemiluminesence reaction.
Statistical analyses
Results are presented as means ± SEM. Parametric
data for cortisol-infused and saline-infused animals
were compared by Student’s t test. The distribution of
placentomes between A/B and C/D classifications in the
two experimental groups was compared by chi-squared
test. The interdependence of umbilical glucose uptake,
maternal and fetal plasma glucose and the transplacental
plasma glucose gradient was determined by Pearson
correlation. In all cases, significance was taken at the level
P < 0.05.
Results
Maternal and fetal plasma hormone and metabolite
concentrations and blood gas status
Maternal cortisol infusion caused a significant increase
in plasma cortisol concentration in the mother, but
not the fetus, on the fifth day of treatment, compared
to saline infusion (Table 1). Plasma concentrations of
insulin, glucose and lactate were also raised in cortisol-
relative to saline-infused ewes (Table 1). In contrast,
these plasma concentrations were unaffected in the
fetus by maternal treatment, although maternal cortisol
infusion did increase fetal plasma concentrations of
fructose compared to controls (Table 1). There was no
significant difference between the two groups of ewes
in the transplacental concentration gradient for plasma
glucose (saline, 2.42 ± 0.10 mmol l−1, n = 19; cortisol,
2.72 ± 0.12 mmol l−1, n = 17; P > 0.05) or lactate
(saline −1.17 ± 0.31 mmol l−1, n = 19; cortisol,
−1.26 ± 0.27 mmol l−1 n = 17; P > 0.05). There was
also no difference in maternal and fetal α-amino nitrogen
concentrations with treatment (Table 1). The pH, PCO2
andHCO3− concentrationofmaternal blood, but not fetal
blood, were higher in cortisol- than saline-infused animals
(Table 1). There were no significant differences in PO2 ,
haemoglobin content or oxygen saturation of maternal or
fetal arterial blood, between saline- and cortisol-infused
sheep (Table 1).
Biometry and blood flow
Maternal cortisol infusion had no effect on the
crown–rump length, body weight or weight of individual
organs of fetuses delivered at day 130 (Table 2).
Neither was there a difference in the total weight and
number of placentomes, or mean placentome weight
between cortisol- and saline-infused animals (Table 2).
In addition, there was no difference between saline- and
cortisol-infused sheep in mean frequency of A/B (saline
75 ± 8%, n = 21; cortisol 71 ± 34%, n = 20) or C/D
(saline 25 ± 8%; cortisol 29 ± 8%; P > 0.05 both cases,
t test) types of placentomes. Umbilical and uterine blood
flows did not differ between saline- and cortisol-infused
ewes (Table 3).
Fetoplacental metabolism
Oxygen. There was no apparent effect of maternal
cortisol infusion on total uterine or umbilical oxygen
uptake (Fig. 1A and Table 3). Uteroplacental oxygen
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Table 1. Mean ± SEM maternal and fetal arterial plasma hormone and metabolite concentrations, and arterial blood gas status of
saline- (n = 8–19) and cortisol- (n = 17–20) infused sheep, on the fifth day of treatment, at day 130 of pregnancy
Mother Fetus
Saline Cortisol Saline Cortisol
Plasma hormones
Cortisol (ng ml−1) 19.0 ± 5.7 41.1 ± 3.4∗ 16.3 ± 1.4 24.9 ± 5.0
Insulin (pg ml−1) 0.213 ± 0.027 0.541 ± 0.090∗ 0.133 ± 0.012 0.137 ± 0.01
Plasma metabolites
Glucose (mmol l−1) 3.29 ± 0.11 3.68 ± 0.13∗ 0.88 ± 0.04 0.97 ± 0.04
Lactate (mmol l−1) 0.67 ± 0.07 0.84 ± 0.05∗ 1.84 ± 0.31 2.10 ± 0.26
α-Amino nitrogen (mmol l−1) 2.43 ± 0.37 2.17 ± 0.26 3.97 ± 0.54 5.10 ± 0.41
Fructose (mmol l−1) † † 1.58 ± 0.21 2.68 ± 0.12∗
Blood gases
pH 7.498 ± 0.008 7.525 ± 0.007∗ 7.352 ± 0.009 7.327 ± 0.013
PO2 (mmHg) 96.2 ± 1.4 94.6 ± 2.7 17.9 ± 0.7 18.3 ± 0.6
PCO2 (mmHg) 33.7 ± 0.5 37.4 ± 1.1∗ 52.5 ± 0.8 54.9 ± 0.9
HCO3− (mmol l−1) 27.2 ± 0.9 30.1 ± 0.7∗ 27.8 ± 0.9 27.8 ± 0.8
Hb (g dl−1) 9.3 ± 0.3 8.7 ± 0.3 9.9 ± 0.4 10.0 ± 0.5
Hb saturation (%) 93.8 ± 0.5 93.8 ± 0.7 51.8 ± 2.5 49.2 ± 1.9
Haematocrit (%) 27.5 ± 0.9 28..2 ± 0.7 31.2 ± 1.3 29.8 ± 1.2
∗P < 0.05 versus saline (t test). †Maternal plasma fructose concentrations were not measured as they are typically  0.1 mmol l−1 and
below the limit of detection of the assay used (Meznarich et al. 1987; Regnault et al. 2010).
Table 2. Mean ± SEM fetoplacental biometrical measurements
from saline- (n = 21) and cortisol- (n = 20) infused sheep on the
fifth day of treatment, at day 130 of pregnancy
Saline Cortisol
Crown–rump length (cm) 43 ± 1 44 ± 1
Weight
Fetus (kg) 2.8 ± 0.1 3.0 ± 0.1
Heart (g) 17 ± 1 19 ± 1
Lungs (g) 74 ± 6 87 ± 6
Liver (g) 82 ± 5 100 ± 7
Kidneys (g) 17 ± 1 19 ± 1
Perirenal fat (g) 12 ± 1 11 ± 1
Adrenals (mg) 332 ± 31 313 ± 21
Brain (g) 38 ± 2 41 ± 1
Total placentomes (g) 305 ± 21 300 ± 19
Mean placentome (g) 4.1 ± 0.4 4.3 ± 0.3
Fetus:Placenta 9.9 ± 0.5 10.4 ± 0.5
Total placentome number 96 ± 21 77 ± 3
consumption also did not differ with maternal treatment
either in absolute value or when expressed on a weight
specific basis (Table 3 and Fig. 1D).
Glucose. Total uterine glucose uptake was similar in the
two groups of ewes (Table 4). In contrast, the absolute
rate of umbilical glucose uptake was significantly lower
in cortisol- than saline-infused animals, due primarily
to a significantly smaller umbilical venous–arterial
concentration difference in blood glucose (Table 3).
Umbilical glucose uptake was also lower in cortisol-
than saline-infused sheep when expressed per kg fetus
(Fig. 1B). Consequently, it accounted for a significantly
smaller percentage of total uterine glucose uptake in
cortisol-treated (34 ± 6%, n = 9) than saline-infused
ewes (54 ± 6%, n = 15; P < 0.05). Conversely, the
percentage of total uterine glucose uptake consumed by
the uteroplacental tissues was greater in cortisol-infused
ewes (cortisol, 66 ± 6%, n = 9; saline, 47 ± 6%, n = 15;
P < 0.05), although absolute and weight specific rates
of uteroplacental glucose consumption did not differ
significantly with treatment (Table 3 and Fig. 1E).
Lactate. Total uteroplacental lactate production was
significantly higher in cortisol- than saline-infused ewes
(Table 3 and Fig. 1F) due to significant increases in both
the umbilical and uterine venous–arterial concentration
differences in blood lactate with maternal cortisol
treatment (P< 0.05, Table 3) Net umbilical lactate uptake
varied between fetuses and did not differ significantly
between the two groups, either as an absolute value
(Table 3, P = 0.06) or when expressed per kilogram fetus
(Fig. 1C, P = 0.07). In contrast, the rate of lactate output
into the uterine circulation doubled in cortisol-infused
ewes, compared to the saline-treated controls (Table 3).
However, therewas no significant change in the percentage
distribution of total uteroplacental lactate production
between the umbilical (cortisol, 58 ± 5%, n = 9; saline,
51 ± 5%, n = 15; P > 0.05) and uterine circulations
(cortisol, 42 ± 5%, n = 9; saline, 49 ± 5%, n = 15;
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Table 3. Mean ± SEM values of uterine and umbilical blood flows and metabolite fluxes in saline- (n = 15) and cortisol- (n = 9)
infused sheep infused sheep on the fifth day of treatment, at day 130 of pregnancy
Saline Cortisol
Blood flow
Umbilical (ml min−1) 615 ± 33 573 ± 55
Umbilical (ml min−1 kg−1) 218 ± 14 193 ± 20
Uterine (ml min−1) 1275 ± 70 1290 ± 81
Uterine (ml min−1 kg−1) 400 ± 14 389 ± 30
Blood oxygen content (mmol l−1)
Umbilical vein 4.65 ± 0.16 4.61 ± 0.42
Umbilical artery 3.17 ± 0.18 2.72 ± 0.28
Umbilical vein–artery 1.48 ± 0.08 1.89 ± 0.22
Uterine artery 5.18 ± 0.21 5.16 ± 0.25
Uterine vein 3.85 ± 0.19 3.73 ± 0.24
Uterine artery–vein 1.27 ± 0.13 1.43 ± 0.09
Umbilical oxygen uptake (μmol min−1) 892 ± 46 1031 ± 111
Uterine oxygen uptake (μmol min−1) 1676 ± 244 1840 ± 154
Uteroplacental oxygen consumption (μmol min−1) 784 ± 228 809 ± 182
Blood glucose (mmol l−1)
Umbilical vein 0.97 ± 0.04 0.92 ± 0.07
Umbilical artery 0.82 ± 0.04 0.81 ± 0.07
Umbilical vein–artery 0.15 ± 0.01 0.12 ± 0.02∗
Uterine artery 2.44 ± 0.12 2.26 ± 0.04
Uterine vein 2.28 ± 0.12 2.10 ± 0.05
Uterine artery–vein 0.15 ± 0.01 0.16 ± 0.02
Umbilical glucose uptake (μmol min−1) 94.2 ± 7.6 65.2 ± 9.9∗
Uterine glucose uptake (μmol min−1) 190.4 ± 15.1 201.8 ± 20.4
Uteroplacental glucose consumption (μmol min−1) 96.2 ± 15.4 136.6 ± 20.3
Blood lactate (mmol l−1)
Umbilical vein 1.29 ± 0.08 1.79 ± 0.32
Umbilical artery 1.21 ± 0.09 1.54 ± 0.23
Umbilical vein–artery 0.08 ± 0.02 0.25 ± 0.11∗
Uterine vein 0.52 ± 0.06 0.58 ± 0.05
Uterine artery 0.49 ± 0.06 0.52 ± 0.05
Uterine vein–artery 0.04 ± 0.01 0.06 ± 0.02∗
Umbilical lactate uptake (μmol min−1) 51.5 ± 11.8 141.2 ± 57.7
Uterine lactate output (μmol min−1) 42.8 ± 4.8 74.0 ± 17.4∗
Uteroplacental lactate production (μmol min−1) 94.3 ± 13.3 215.2 ± 67.7∗
∗P < 0.05 versus saline (t test).
P > 0.05) with maternal treatment. Placental activity of
lactate dehydrogenase was also unaffected by maternal
treatment (saline 18.4 ± 1.5 U g−1 n = 7; cortisol
15.9 ± 1.4 U g−1 n = 10; P > 0.05).
Placental glucose transport capacity
Per kilogram of placenta, transplacental clearance of the
non-metabolizable glucose tracer, [3H]MeDG, was 40%
greater in cortisol- than saline-treated ewes (Fig. 2A).
Concomitantly, placental expression of the facilitative
glucose transporter gene, SLC2A8, was 38% higher in
cortisol- than saline-infused animals (Fig. 2B). In contrast,
placental expression of the SLC2A1 and SLC2A3 genes was
unaffected by maternal treatment (Fig. 2B). There was
no significant effect of maternal treatment on placental
protein content (saline, 108 ± 9 mg g−1, n = 7; cortisol,
109 ± 7 mg g−1, n = 10; P > 0.05).
Hepatic glucogenic capacity
Elevating cortisol concentrations reduced the protein
content but increased glycogen content of maternal liver
relative to saline infusion on day 130 of pregnancy
(Table 4). However, there was no difference in fetal
hepatic protein or glycogen contents between the saline
and cortisol groups. Neither was there a significant
alteration in activity of the gluconeogenic enzymes,
glucose-6-phosphatase and fructose-1,6-bisphosphatase,
in either maternal or fetal liver. Cortisol infusion led to
significantly higher lactate dehydrogenase activity in fetal,
but not maternal, liver than seen with saline infusion
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(Table 4). There were no significant differences in hepatic
G6PC or PCK1 gene expression between treatment groups
in either the mother or fetus (P > 0.05, data not shown).
Glucocorticoid bioavailability
Glucocorticoid receptor (GR) gene expression did not
differ between the saline- and cortisol-infused groups in
the placenta, maternal or fetal liver or in fetal skeletal
muscle (Table 5). Neither was there an effect of maternal
cortisol infusion on gene expression of the glucocorticoid
metabolizing enzymes,HSD1 (placenta,maternal and fetal
liver and fetal skeletal muscle) and HSD2 (placenta only)
(Table 5).
Fetal insulin receptor signalling
Insulin receptor (IR) protein abundance was significantly
greater in the placenta of cortisol-infused animals but
did not differ in fetal liver or skeletal muscle, relative to
controls (Fig. 3). Maternal cortisol infusion had no effect
on fetal hepatic or skeletal muscle Akt protein abundance,
or its phosphorylation at the serine-473 residue, key
signalling molecules downstream of the IR (Fig. 3).
Discussion
This study is the first to show that increasing maternal
cortisol concentrations within the physiological range
during sheep pregnancy alter uteroplacental metabolism
with consequences for the supply of nutrients to the
fetus. When maternal plasma cortisol was raised by
intravenous infusion, a greater percentage of the total
amount of glucose taken up by the gravid uterus
was used by the uteroplacental tissues with the result
that proportionately less glucose was available for
onward transfer to the fetus. The reduction in net
umbilical glucose uptake occurred despite increases in
placental glucose transporter expression and glucose
transport capacity measured as [3H]MeDG clearance.
Concomitantly, lactate was produced at a higher rate
by the uteroplacental tissues of cortisol-treated ewes and
distributed into both the fetal and maternal circulations
without any change in uteroplacental consumption or
umbilical uptake of oxygen. The cortisol-induced rise
in uteroplacental lactate production was associated with
increased maternal but not fetal lactate concentrations
and with enhanced lactate dehydrogenase activity in fetal
but not maternal liver. Maternal cortisol concentrations,
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Figure 1. Mean ± SEM umbilical uptake (A–C) and uteroplacental consumption/production of oxygen
(A andD), glucose (B and E) and lactate (C and F), expressed per kg fetus or per kg placenta, respectively,
on the fifth day of infusion with saline (n = 15) or cortisol (n = 9), at day 130 of pregnancy
∗P < 0.05 versus saline (t test).
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Table 4. Mean ± SEM protein and glycogen contents, and glucogenic enzyme activities in maternal and fetal liver of saline- (n= 7–10)
and cortisol- (n = 10–20) infused sheep collected at postmortem on the fifth day of infusion, on day 130 of pregnancy
Maternal liver Fetal liver
Saline Cortisol Saline Cortisol
Protein (mg g–1) 159 ± 8 144 ± 3∗ 124 ± 2 123 ± 3
Glycogen (mg g–1) 17 ± 2 39 ± 3∗ 20 ± 3 21 ± 3
G6Pase activity (U g–1) 14.3 ± 1.4 13.1 ± 0.8 1.7 ± 0.3 2.5 ± 0.4
FBPase activity (U g–1) 3.4 ± 0.6 5.4 ± 1.0 7.1 ± 0.6 6.7 ± 0.7
LDH activity (U g–1) 10.5 ± 1.3 11.0 ± 0.5 8.2 ± 0.7 10.5 ± 0.6∗
∗P < 0.05 versus saline (t test). FBPase, fructose-1,6-bisphosphatase; G6Pase, glucose-6-phosphatase; LDH, lactate dehydrogenase.
therefore, appear to regulate uteroplacental metabolism
and glycolysis, in particular, to vary the availability of
different carbohydrates for fetal use.
Cortisol administration increased plasma cortisol
concentration in the ewe by 100% on the final day of
infusion, in line with observations made during cortisol
infusion at the same dose over a more prolonged period
in late pregnancy (Jensen et al. 2005; Reini et al. 2008;
Keller-Wood et al. 2014). However, in contrast to these
previous studies, fetal cortisol concentrations were not
significantly raised after 5 days of maternal cortisol
infusion. In the current study, the rise in maternal
plasma cortisol concentrations was accompanied by a
decline in hepatic protein content and increases in the
plasma insulin and glucose concentrations, blood pH and
HCO3− concentration and in the hepatic glycogen content
of the mother, consistent with the known actions of
glucocorticoids on adult insulin sensitivity and renal and
hepaticmetabolism (Holness & Sugden, 2001; Jensen et al.
2002a; Franko et al. 2007; Koeppen, 2009; Keller-Wood
et al. 2014). Since cortisol treatment had no effect on gene
expression of GR or 11β-hydroxysteroid dehydrogenase
enzyme isoforms in the placenta, maternal or fetal liver,
the maternal and fetal metabolic changes seen with this
treatment aremost likely to be due to the increased cortisol
concentration in the maternal circulation mediated in
the fetus by the concomitant changes in uteroplacental
metabolism and nutrient delivery.
Net umbilical glucose uptake was reduced by 30%
in response to maternal cortisol treatment in the pre-
sent study, despite increases in both placental GLUT8
expression and [3H]MeDG clearance. There were also
no changes in the actual rates of uterine glucose uptake,
uteroplacental glucose consumption and umbilical blood
flow or in the transplacental plasma glucose concentration
gradient which could explain the fall in umbilical
glucoseuptakewith treatment. Sinceuteroplacental lactate
production increased more than 2-fold with maternal
cortisol treatment, the most plausible explanation for
the decreased umbilical glucose uptake is that glucose is
diverted from transplacental transfer into uteroplacental
lactate synthesis.
Lactate production can occur either by increased
flux through the glycolytic pathway or by diverting
pyruvate from oxidative metabolism directly or as a
result of impaired mitochondrial function. There was
no change in uteroplacental oxygen consumption in the
cortisol-treated ewes in the current study, which suggests
that mitochondrial oxidative function was not affected
significantly by maternal treatment. Neither was there
any change in placental activity of lactate dehydrogenase,
the enzyme responsible for interconverting pyruvate and
lactate. Since the fall in umbilical glucose uptake with
maternal cortisol treatment could account for only about
half of the increase in uteroplacental lactate production,
either a greater proportion of the glucose normally
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Table 5. Mean ± SEM relative expression of genes related
to glucocorticoid bioavailability in maternal and fetal liver of
saline- (n = 8–10) and cortisol- (n = 14–20) infused sheep
collected at postmortem on the fifth day of treatment, on day
130 of pregnancy
Saline Cortisol
Maternal liver
GR 1.00 ± 0.07 0.91 ± 0.03
HSD1 1.00 ± 0.04 0.87 ± 0.05
Fetal liver
GR 1.00 ± 0.08 1.10 ± 0.07
HSD1 1.00 ± 0.10 1.13 ± 0.10
Fetal muscle
GR 1.00 ± 0.09 1.11 ± 0.18
HSD1 1.00 ± 0.09 1.34 ± 0.24
Placenta
GR 1.00 ± 0.07 1.19 ± 0.10
HSD1 1.00 ± 0.26 0.84 ± 0.12
HSD2 1.00 ± 0.12 0.84 ± 0.11
consumed by the uteroplacental tissues was used for
lactate productionor lactatewas produced fromglucose or
fructose derived from the fetal circulation. Fetal fructose
concentrations were higher in the cortisol-treated ewes
in the present study and previous studies have shown
that lactate can be synthesized by uteroplacental tissues
from both fetal glucose and fructose in normal, unstressed
ewes, albeit at low rates (Sparks et al. 1982; Meznarich
et al. 1987; Hay et al. 1990). In normal conditions,
fructose is produced endogenously and accumulated at
high concentrations within the conceptus, both as an
energy source and organic osmolyte (Teng et al. 2002;
Jauniaux et al. 2005). Although it is unclear whether
increased fetal fructose concentrations in this study are
derived from the placenta or fetal liver (Britton et al. 1967;
Regnault et al. 2010), enhanced fructogenesis is likely to
parallel increased blood glucose levels in the ewe and may
act to regulate cellular redox potential in the fetus during
maternal cortisol infusion (Huggett et al. 1951; Jauniaux
et al. 2005; Brown et al. 2014). Since GLUT8 transports
glucose and fructose (Debosch et al. 2014), upregulationof
placental SLC2A8 expression bymaternal cortisol infusion
may enhance the availability of both fetal glucose and
fructose for uteroplacental lactate synthesis.
Previous studies have also shown increased placental
expression of fatty acid and amino acid transporters when
maternal glucocorticoids are raised by undernutrition or
exogenous administration in sheep and mice, respectively
(Fowden & Silver, 1985; Ma et al. 2011). This may
provide more fat and amino acids as alternative substrates
to maintain oxidative metabolism of the uteroplacental
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Figure 3. Mean ± SEM relative abundance (A) and representative Western blots (B) of insulin signalling
proteins in fetal liver, muscle and placenta of saline- and cortisol-infused sheep
∗P < 0.05 versus saline (t test).
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tissues in the face of their increased glycolytic use of
glucose.
The molecular mechanisms by which cortisol alters
uteroplacental metabolism remain largely unknown. In
other tissues, aerobic glycolysis is activated by the
PI3K–Akt pathway through which insulin and other
hormones act (Vander Heiden et al. 2009). Even though
there were no changes in placental expression or
phosphorylation of Akt per se in the current study, the
enhanced placental IR expression together with the raised
maternal insulin concentrations in the cortisol-treated
ewes suggests that activation of the PI3K–Akt signalling
pathway may be involved in regulating uteroplacental
metabolism. Certainly, in previous studies, altered
placental PI3K–Akt signalling accompanies the adaptive
changes in placental morphology and nutrient transport
activity induced by dietary or other stressful challenges
during pregnancy in sheep and mice (Arroyo et al. 2010;
Zhu et al. 2010; Ma et al. 2011; Sferruzzi-Perri et al. 2011;
Vaughan et al. 2015; Higgins et al. 2016).
Whatever the mechanisms involved, the cortisol-
initiated switch from supplying carbohydrate to the fetus
primarily as glucose to a greater dependence on lactate
will have consequences for fetalmetabolism and acid–base
balance. Lactate can be used for both oxidative and
non-oxidative metabolism in fetal sheep (Sparks et al.
1982; Hay et al. 1983). It can also be converted to glucose
by hepatic gluconeogenesis to supply fetal tissues like the
brain, with little capacity to use lactate, particularly when
glucose availability is limited (Jones et al. 1975; Levitsky
et al. 1988; Bissonnette et al. 1991). The increased lactate
dehydrogenase activity in the fetal liver of cortisol-treated
ewes is consistent with the possibility of increased
gluconeogenesis from lactate, although there were no
changes in expression or activity of key gluconeogenic
enzymes in the fetal liver with maternal treatment. The
greater fetal provision of lactate with maternal cortisol
treatment may be a mechanism to limit the rise in fetal
glucose levels in response to the concomitant maternal
hyperglycaemia. Indeed, a significant increase in both
maternal and fetal lactate concentrations occurs when
maternal blood glucose levels are raised over a more
prolonged, 10 day period of cortisol infusion in late
pregnancy (Jensen et al. 2005). In normal conditions,
increases in fetal glucose concentrations stimulate fetal
insulin secretion and lead to increased fetal glucose uptake
and growth, which would be an inappropriate response at
a time of maternal stress when cortisol levels are high
and more nutrients may be required by maternal tissues
(Fowden & Forhead, 2009). Certainly, there were no
changes in fetal insulin concentrations or gene expression
of IR andAkt in fetal liver or skeletal muscle withmaternal
cortisol treatment in the current study, which might
have altered fetal glucose utilization independently of the
glucose supply. Neither did mean fetal body weight differ
from control values in this or previous studies of longer
cortisol infusions, although growth of individual fetuses,
measured as girth increment, is reduced by the end of
10 days ofmaternal cortisol treatment (Jensen et al. 2002b;
Reini et al. 2008; Keller-Wood et al. 2014).
In summary, maternal cortisol treatment adapts
uteroplacental metabolism by increasing both glycolytic
production of lactate and oxidative use of substrates
in addition to glucose. Since the total net umbilical
supply of carbohydrate carbonwas unaffected bymaternal
treatment, the cortisol-induced switch in uteroplacental
metabolism toprovide the fetuswith less glucose andmore
lactate carbonmay allowmore maternal control over fetal
metabolism and growthwhile still providing the fetuswith
an adequate carbohydrate supply to meet its immediate
needs. Indeed, in increasing lactate production aerobically,
the uteroplacental tissues of the cortisol-treated ewes
may be reverting to the metabolic strategy of the early
embryo in using aerobic glycolysis to accumulate biomass
and regulate the redox state of metabolically active,
proliferating cells (Jauniaux et al. 2005; Krisher & Prather,
2012).Overall, thefindings indicate that theovineplacenta
can integrate maternal signals of adversity with fetal
signals of nutrient demand in determining its metabolic
phenotype. Whilst these adaptations in uteroplacental
metabolism may be beneficial for fetal and maternal
survival in the short term, prolonged uteroplacental
production and fetal delivery of lactate, for instance, may
have adverse consequences in the longer term and explain
previous findings of poor fetal viability in ewes infused
with cortisol for several weeks during late pregnancy
(Keller-Wood et al. 2014).
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